Tuesday, September 25, 2012

latest news

RBC Capital believes that Phase II PEG-PAL data and Phase I Achondroplasia safety data could be announced next week, 

http://wallstcheatsheet.com/stocks/biomarin-retains-outperform-rating-and-4-stock-analyses-sparking-chatter.html/



Posted by Amer Haider's Blog at 11:10 AM

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)